EP 3937928 A1 20220119 - CAPSID ASSEMBLY MODULATOR SOLID FORMULATION
Title (en)
CAPSID ASSEMBLY MODULATOR SOLID FORMULATION
Title (de)
FESTE FORMULIERUNG EINES KAPSIDANORDNUNGMODULATORS
Title (fr)
FORMULATION SOLIDE DE MODULATEUR D'ASSEMBLAGE DE CAPSIDE
Publication
Application
Priority
- US 201916352754 A 20190313
- IB 2019000231 W 20190313
- EP 2019056348 W 20190313
- EP 19197566 A 20190916
- EP 2020056991 W 20200313
Abstract (en)
[origin: WO2020183020A1] The present disclosure is directed to solid oral dosage forms of a capsid assembly inhibitor for the treatment of hepatitis B virus infection.
IPC 8 full level
A61K 31/40 (2006.01); A61K 9/20 (2006.01)
CPC (source: EP IL KR)
A61K 9/146 (2013.01 - EP IL); A61K 9/1652 (2013.01 - KR); A61K 9/2054 (2013.01 - EP IL KR); A61K 31/40 (2013.01 - EP IL KR); A61P 31/00 (2018.01 - EP IL); A61P 31/20 (2018.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020183020 A1 20200917; AU 2020235442 A1 20210812; BR 112021017525 A2 20211123; CA 3132095 A1 20200917; CN 113557016 A 20211026; CR 20210481 A 20211025; EC SP21067052 A 20211118; EP 3937928 A1 20220119; IL 286209 A 20211031; JO P20210250 A1 20230130; JP 2022524819 A 20220510; KR 20210137484 A 20211117; MA 55280 A 20220119; MX 2021011030 A 20211013; PE 20212107 A1 20211104; SG 11202109710Q A 20211028
DOCDB simple family (application)
EP 2020056991 W 20200313; AU 2020235442 A 20200313; BR 112021017525 A 20200313; CA 3132095 A 20200313; CN 202080020501 A 20200313; CR 20210481 A 20200313; EC DI202167052 A 20210910; EP 20709618 A 20200313; IL 28620921 A 20210909; JO P20210250 A 20200313; JP 2021554750 A 20200313; KR 20217031285 A 20200313; MA 55280 A 20200313; MX 2021011030 A 20200313; PE 2021001464 A 20200313; SG 11202109710Q A 20200313